Population Pharmacokinetics of Clarithromycin in Healthy Adult Korean

클라리스로마이신의 건강한 한국 성인에 대한 집단 약물동태

  • Published : 2002.02.01

Abstract

The purpose of this study was to estimate the population pharmacokinetics of clarithromycin in healthy adult Korean and to investigate the factors influencing the pharmacokinetics of clarithromycin. The population pharmacokinetic parameters of clarithromycin were calculated with the data from healthy adult Koreans. A total of 798 plasma concentrations obtained from 78 subjects after administration of a single oral dose of 250 mg or 500 mg were used for the modeling. The concentration-time data were fitted to a one-compartment open model assuming a first-order absorption and elimination with no lag time. The correlations between various factors [such as sex, age, height, weight, sect creatinine (Scr) and dose and pharmacokinetic parameters were estimated with stepwise linear recession analyses. The selected covariates were incorporated in the population model of NONMEM, and the importance of each covariate was investigated by means of backwards elimination. The apparent clearance (CL/F) was significantly correlated to Scr and sex, and the apparent volume of distribution (Vd/F) was significantly correlated to Scr and height in a nonlinear relationship. The population values of Ka was 1.8 h $r_{-1}$, CL/F was 37.71 L/hr, Vd/F was 200 L and t/ sub 1/2 / was 3.68 hrs for a male Korean with 170 m height and 1.0 mg/dL Scr.

Keywords

References

  1. Antimicrobial Agents and Chemotherapy v.36 Absolute bioavailability of clarithromycin after oral administration in humans Chu S. Y.;Deaton R;Cavanaugh J.
  2. Journal of Hospital Infection 19(suppl. A) The Pharmacokinetics of clarithromycin and its 14-OH metabolite Davey P. G.
  3. Journal of Clinical Pharmacology v.32 Drug-food interaction potential of clarithromycin, a new macroride antimicrobial Chu S. Y.;Park Y.;Locke C.;Wilson D. S.;Cavanaugh C.
  4. Drug Metabolism and Disposition v.18 Metabolism and disposition of clarithromycin in man Ferrero J. L.;Bopp B. A.;Marsh K. C.;Quigley S. C.;Johnson M. J.(et al.)
  5. Journal of Clinical Pharmacology 32 Clarithromycin pharmacokinetics in healthy young and elderly volanteers Chu S. Y.;Wilson D. S.;Guay D. R.;Craft C.
  6. Journal of Clinical Pharmacology v.33 Single- and multiple-dose pharmacokinetics of clarithromycin, a new macroride antimicrobial Chu S. Y.;Wilson D. S.;Deaton R.;Mackenthun A. V.;Eason C. N.;Cavanaugh J.